State Street Corp Incyte Corp Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Incyte Corp stock. As of the latest transaction made, State Street Corp holds 9,899,546 shares of INCY stock, worth $572 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,899,546
Previous 10,120,170
2.18%
Holding current value
$572 Million
Previous $635 Million
11.25%
% of portfolio
0.03%
Previous 0.03%
Shares
17 transactions
Others Institutions Holding INCY
# of Institutions
616Shares Held
215MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.09 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.34 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.31 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$891 Million0.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.68MShares$328 Million0.51% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $12.9B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...